Polar Capital Holdings Plc 13D and 13G filings for Enliven Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:17 am Sale |
2024-12-31 | 13G | Enliven Therapeutics, Inc. ELVN |
Polar Capital Holdings Plc | 2,389,668 4.890% |
-298,129 (-11.09%) |
Filing |
| 2024-11-13 5:55 pm Purchase |
2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN |
Polar Capital Holdings Plc | 2,687,797 5.690% |
2,687,797 (New Position) |
Filing |